Excessive weight loss aided by bariatric (weight loss) surgery has been linked to improved symptoms in people with psoriasis and psoriatic arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Injections of corticosteroids in the knee joints appear to be safe, but not effective, according to the findings of a two-year clinical trial presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Resistance strength training reduces pain and increases function and treatment satisfaction in people with hand osteoarthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Spacing exercise-based physical therapy sessions over a 12-month period while using three additional “booster” sessions periodically has been shown to be more cost effective than alternative physical therapy strategies in the treatment of knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Mycophenolate mofitil is as effective as cyclophosphamide in treating interstitial lung disease in people with scleroderma, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
People diagnosed with rheumatoid arthritis after the year 2000 don’t have as much of an increased risk of death as people diagnosed before 2000, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco. This, suggests the researchers involved in the study, is likely due to better treatments that focus on eradicating inflammation – a major contributor to the increased risk of death in RA
Two studies, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, show a person’s diet can significantly affect his or her chance of developing rheumatoid arthritis.
A new study, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, shows rheumatoid arthritis patients who don’t respond to an anti-TNF experience better outcomes if they are prescribed a biologic therapy next instead of following the common practice of trying a second anti-TNF. The same researchers found (in a second study also presented at the ACR Annual Meeting) assessing the antidrug antibodies in these patients may help guide the selection of the next treatment option.
The presence of tophi – crystal deposits of uric acid found on the surface of the joints or in the skin and cartilage – in people with gout can increase their risk of developing cardiovascular disease, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
A new study, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, shows certain fractures due to osteoporosis can cause premature death in people 45 and older. This is the largest study, to date, that shows a connection between these fractures and premature death.
Being overweight or obese can reduce the likelihood of achieving sustained remission of early rheumatoid arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
A new study, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, shows that treating rheumatoid arthritis patients toward a target of remission or low disease activity works immediately and leads to higher remission rates.
Cardiovascular disease deaths are declining in people who have been diagnosed with rheumatoid arthritis after the year 2000, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco. This decline is found when compared to people diagnosed with RA in previous decades as well as when compared to people without the disease – signifying an encouraging milestone.
A diagnosis of arthritis in a baby boomer doesn’t mean that person should exit the workforce. Two studies, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, show this growing group often returns to work after retirement and takes little advantage of workplace accommodations for their disease.
Anikinra may offer hope for rheumatology patients with the heart condition
Both Tai Chi and physical therapy positively impact pain, function and other symptoms of knee osteoarthritis – making Tai Chi a viable treatment alternative for people suffering with the degenerative disease, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Using a pedometer to measure the number of steps one takes in a day has been linked to lower fatigue in persons with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
For the first time, chondroitin sulfate has been more successful than celecoxib in reducing the long-term progression of knee osteoarthritis (OA), according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Twenty-five rheumatology state societies, multiple Area Health Education Centers, Arthritis Foundation chapters and the National Association of Chronic Disease Directors have already committed to participate in the immediate effort to implement Lupus education in their local communities and provider networks.
The American College of Rheumatology (ACR) has released new recommendations for the treatment of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (SpA). The guideline summarizes recommendations for both pharmacologic and non-pharmacologic treatments, including rehabilitation, management of patients with comorbid conditions, use of certain surgeries and approaches to patient monitoring.
The American College of Rheumatology (ACR) has released two new publications –recommendations aimed at improving the treatment of patients with polymyalgia rheumatica (PMR), and new classification criteria for gout.
The American College of Rheumatology (ACR) today praised the Food and Drug Administration (FDA) for issuing draft guidance requiring separate and distinct names for biosimilars and biologic therapies.
The American College of Rheumatology has released a statement outlining the ACR’s position on the American Board of Internal Medicine’s (ABIM’s) Maintenance of Certification (MOC) requirements containing seven positions the College requests the ABIM to consider.
The new website combines a user-friendly design with accessible navigation, a robust internal search engine, visitor personas that allow users to quickly find relevant content, and a responsive design that adapts to each visitor’s viewing platform to provide an optimal user experience.
Registration is now open to journalists planning to attend the 2015 ACR/ARHP Annual Meeting.
Official statement from the American College of Rheumatology on the King v. Burwell Supreme Court ruling and what this means for the rheumatology community.
The American College of Rheumatology (ACR) today expressed its support for the ICD-TEN Act (H.R. 2247), a bill introduced by Representative Diane Black (R-TN) to ensure a reasonable and responsible transition to ICD-10.
Raman spectroscopy (RS) used at point of service could reduce the need for inpatient admission in patients with gout and pseudogout, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Carefully employing a TNF inhibitor dose-reduction strategy can be just as effective at safely treating RA patients as regular dosing methods, while also saving approximately $7,500 per patient annually.
Inflammation related to synovitis or effusion may drive increased sensitization in knee osteoarthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Physically demanding jobs may increase the effects of inflammation on the progression of ankylosing spondylitis, possibly leading to increased bone formation in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Patients with hip and knee osteoarthritis may improve their pain, stiffness and physical function with sustained physical exercise, manual therapy or both, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Mortality risk for patients with rheumatoid arthritis is reduced to that of the general population when patients are treated with the aim to meet a low disease activity score, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Secukinumab, an anti-IL-17A monoclonal antibody biologic drug, showed promise as a treatment for patients with active ankylosing spondylitis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Rheumatologists at Geisinger Health System in Central Pennsylvania have developed a new model of rheumatoid arthritis patient care that is designed to improve quality while reducing costs, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Baseline levels of serum interferon in rheumatoid arthritis patients may help rheumatologists determine who will have a poor response to tumor necrosis factor-alpha inhibitor drugs, and one day help rheumatologists determine the best treatment options for individual RA patients.
Women with rheumatoid arthritis are at significantly higher risk of all-cause mortality, particularly respiratory causes, compared to women without the disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Not only does treatment with tumor necrosis factor (TNF) inhibitor biologic drugs not increase the risk of congestive heart failure in people with rheumatoid arthritis, but it may decrease the incidence of this serious cardiovascular disease in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Patients with rheumatic diseases who are treated with denosumab (Prolia®, Xgeva®) either alone, or in combination with either biologic or non-biologic disease-modifying antirheumatic drugs (DMARDs), do not appear to have a significant increased risk of infections.
Use of antibiotics is associated with an increased risk of children developing juvenile idiopathic arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
People age 30 or over with autoimmune, inflammatory diseases like rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease, may benefit from vaccinations for the viral infection herpes zoster, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Hydroxychloroquine (Plaquenil®), especially at the higher standard dose of 400 mg per day, independently decreases the risk of cardiovascular morbidity in people with rheumatoid arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
People with rheumatoid arthritis who are currently taking biologic drugs may be safely vaccinated for the viral infection herpes zoster, according to new research findings presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
Women using intrauterine devices (IUDs) may be at increased risk for producing autoantibodies related to the risk of developing rheumatoid arthritis (RA), according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Patients with end-stage lung disease due to systemic sclerosis should not simply be denied lung transplantation because of short- and long-term survival concerns due to extra-pulmonary factors, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Better clinical care and compliance might prevent most gout cases that require hospitalization, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Running as a habitual exercise at any stage in life not only does not increase a person’s risk of developing knee osteoarthritis and may even help protect a person from developing the painful disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Denosumab (Prolia®, Xgeva®) reversed cortical bone loss and increased bone mineral density, lowering wrist fracture rates in women with osteoporosis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Learning that your child has arthritis can lead to a number of questions and concerns about treatment options and prognosis. But, partnering with your child and his or her rheumatologist in shared decision making about their health care can lead to better outcomes overall, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Rituximab (Rituxan®) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener’s), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right